Yongrong Wu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 3
- Cancer, Lipids, and Metabolism 2
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Flavonoids in Medical Research 4
-
- Cancer Mechanisms and Therapy 3
-
- Liver Disease Diagnosis and Treatment 3
-
- Pancreatic and Hepatic Oncology Research 3
-
- Renal cell carcinoma treatment 2
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Yongrong Wu
25 papers receiving 671 citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 188
- Hepatology 62
- Emergency Medicine 46
- Surgery 209
- Molecular Medicine 22
Countries citing papers authored by Yongrong Wu
This map shows the geographic impact of Yongrong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongrong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongrong Wu more than expected).
Fields of papers citing papers by Yongrong Wu
This network shows the impact of papers produced by Yongrong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongrong Wu. The network helps show where Yongrong Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yongrong Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 5 | |
| 6 | The global, regional, and national burden of appendicitis in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019breakdown → | 2023 | 49 |
| 7 | 2022 | 9 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 24 | |
| 12 | 2022 | 56 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 87 | |
| 15 | 2020 | 5 | |
| 16 | 2020 | 82 | |
| 17 | 2020 | 28 | |
| 18 | 2019 | 37 | |
| 19 | 2019 | 9 | |
| 20 | 2011 | 10 |
About Yongrong Wu
Yongrong Wu is a scholar working on Hepatology, Cancer Research and Molecular Medicine, having authored 27 papers that have together received 678 indexed citations. Recurring topics across this work include Flavonoids in Medical Research (4 papers), Cancer Mechanisms and Therapy (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer-related molecular mechanisms research (3 papers), Renal cell carcinoma treatment (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (188 citations), Hepatology (62 citations) and Emergency Medicine (46 citations). Yongrong Wu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Gaoyan Kuang, Xiaoyun He, Chunlin Ou, Guangdong Pan, Guoqing Ouyang, Wuchang Lu, Shuai Li, Xiang Chen, Qiang Liu and Zhen Liu. Their work appears in journals such as Frontiers in Pharmacology, Journal of Cancer, Cancer, Liver International and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.